Monteris Medical Raises $28 Million in Series E Funding
Monteris Medical, based in Minnetonka, Minnesota, has successfully raised $28 million in a Series E funding round. The company is known for its commitment to providing clinicians with the clinical evidence necessary to make informed care decisions, particularly in the field of laser interstitial thermal therapy (LITT).
Investors and Leadership
The funding round was led by InnovaHealth Partners and Birchview Capital, LP. Additional investment came from OSF Ventures, OSF HealthCare, and the Colorado University Healthcare Innovation Fund. Marty Emerson, President and CEO of Monteris Medical, leads the company in its mission to advance clinical evidence and improve patient care.
Use of Funds
While specific plans for the new funds were not detailed, such capital is typically used to enhance product offerings, expand clinical trials, or increase market reach. Given Monteris Medical's focus on clinical evidence and LITT, it is likely the funds will support continued research and development in these areas.
Strategic Implications
This latest round of funding represents a significant step for Monteris Medical as it continues to innovate in medical technology. By securing substantial investment, the company is well-positioned to further its research efforts and potentially expand its influence within the healthcare sector.
Conclusion
Monteris Medical's successful Series E funding round underscores the confidence investors have in its mission and capabilities. With the support of prominent investors, the company is set to continue its work in advancing clinical evidence and providing valuable solutions to healthcare professionals and their patients.